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Gammaherpesvirus BoHV-4 infects 
bovine respiratory epithelial cells mainly 
at the basolateral side
Bo Yang1,2 , Jiexiong Xie1, Jolien Van Cleemput1, Ruifang Wei1, Geert Opsomer2 and Hans J. Nauwynck1*
Abstract 
Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus that is widespread in cattle. However, only a few studies about 
the pathogenesis of BoHV-4 primary infection have been reported. In the present study, ex vivo models with bovine 
nasal and tracheal mucosa explants were used to study the cellular BoHV-4-host interactions. Infection was observed 
in nasal but not in tracheal epithelial cells. To find a possible correlation between the integrity and restricted infec-
tion of the respiratory epithelium, both nasal mucosal and tracheal explants were treated with EGTA, a drug that 
disrupts the intercellular junctions, before inoculation. The infection was analyzed based on the number of plaques, 
plaque latitude and number of infected single cells, as determined by immunofluorescence. BoHV-4 infection in 
nasal mucosal explants was enhanced upon opening the tight junctions with EGTA. Infection in tracheal explants 
was only found after treatment with EGTA. In addition, primary bovine respiratory epithelial cells (BREC) were isolated, 
grown at the air–liquid interface and infected either at the apical or basolateral side by BoHV-4. The results showed 
that BoHV-4 preferentially bound to and entered BREC at the basolateral surfaces of both nasal and tracheal epithelial 
cells. The percentage of BoHV-4 infection was significantly increased both from nasal and tracheal epithelial cells after 
treatment with EGTA, which indicates that the BoHV-4 receptor is mainly located at the basolateral surface of these 
cells. Thus, our findings demonstrate that integrity of the respiratory epithelium is crucial in the host’s innate defense 
against primary BoHV-4 infections.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Bovine herpesvirus 4 (BoHV-4) is a member of the fam-
ily Herpesviridae, subfamily Gammaherpesvirinae, genus 
Rhadinovirus [1]. BoHV-4 was isolated for the first 
time from animals with respiratory and ocular signs in 
Europe in 1963 [2]. BoHV-4 is widespread in bovine and 
remains latent and asymptomatic in the vast majority of 
infected animals. Viral replication can be reactivated by 
corticosteroids or stress, both factors present at calving 
[3]. Although BoHV-4 has been demonstrated in many 
tissues, accumulated evidence suggests that cells of the 
monocyte/macrophage lineage are the main site of per-
sistence in both natural and experimental hosts [4].
There are several innate mucosal barriers between 
gammaherpesviruses and their hosts, which include the 
mucus layer, the mucociliary escalator, antimicrobial pep-
tides and firm intercellular connections [5]. The airway 
surface liquid (ASL), often referred to as mucus, is the 
first layer of defense against incoming pathogens through 
mucociliary clearance. Intercellular junctions (ICJ) of 
the respiratory epithelium are crucial in the host’s innate 
defense against primary infection with alphaherpesvi-
rus equine herpesvirus type 1 (EHV-1) [6]. Therefore, 
we hypothesized that intercellular junctions (ICJ) may 
play a similar important role for gammaherpesviruses in 
protecting the respiratory mucosa from primary replica-
tion. ICJ are specialized regions of contact between the 
plasma membranes of adjacent cells and form the apical 
cell domain, separating the external environment from 
the basolateral cell domains, which contacts the underly-
ing cells and systemic vasculature [7].
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Virus binding and subsequent entry may occur selec-
tively at either the apical or basolateral domains of polar-
ized cells, due to the specific expression of receptors 
required for binding and internalization. Some viruses, 
such as simian virus, hepatitis A virus and West Nile 
virus preferentially infect polarized cells at the apical sur-
faces [8–10], while vesicular stomatitis virus (VSV), Sem-
liki Forest virus and EHV-1 prefer basolateral surfaces [6, 
11, 12]. In respiratory epithelial cells, polarity of infec-
tion and the importance of ICJ have not been studied for 
gammaherpesviruses. Previous studies with a continuous 
cell line do not really reflect the in vivo situation [13, 14]. 
Therefore, a respiratory mucosal explant model, which 
mimics the in vivo situation, was used to investigate the 
importance of ICJ for the respiratory infection of the 
gammaherpesvirus BoHV-4. In addition, primary bovine 
respiratory epithelial cells (BREC) were isolated and cul-
tivated on transwells to illustrate the polarity of BoHV-4 
binding and subsequent viral replication.
In a previous study, ex  vivo models with bovine geni-
tal tract mucosa explants were set up to elucidate the 
mucosal dissemination and invasion of BoHV-4 [15]. 
BoHV-4 replicates in the epithelial cells of uterus, cervix 
and vagina in a plaquewise manner and does not cross 
the basement membrane.  Instead, it hijacks individual 
 CD172a+ monocytic cells to invade the underlying con-
nective tissue. During this migration, the BoHV-4 rep-
lication is silenced, because fibrocytes do not become 
infected. When BoHV-4 become produced in connective 
tissue (e.g. upon reactivation), fibrocytes may become 
infected and may eventually lead to pathological pro-
cesses [15]. In the present study, respiratory mucosal 
explants and BREC were used to describe the invasion 
mechanism of gammaherpesvirus BoHV-4.
Materials and methods
Virus strain
The BoHV-4 strain V.test was used in this study, which 
belongs to the European clade of BoHV-4 strains. It was 
originally isolated from an infertile bull’s testicle. The 
strain V.test had previously received an unknown number 
of passages. The virus was passaged three times in Madin 
Darby Bovine Kidney (MDBK) cells in our laboratory.
Tissue collection and processing
The nasal and tracheal mucosae were collected from 
healthy cattle at the local slaughterhouse and were 
immediately placed in phosphate buffered saline (PBS), 
supplemented with 1000  U/mL penicillin (Continental 
Pharma, Puurs, Belgium), 1 mg/mL streptomycin (Certa, 
Braine l’Alleud, Belgium), 1 μg/mL gentamycin (Invitro-
gen, Paisley, UK) and 5 μg/mL fungizone (Bristol-Myers 
Squibb, New York, USA) on ice for transportation to the 
laboratory. Nasal septum mucosal explants and trachea 
mucosal explants were prepared as previously described 
[15]. Primary bovine nasal and tracheal epithelial cells 
were isolated and cultured as described by Van Cleemput 
et al. [6].
Disruption of intercellular junctions
Respiratory mucosa explants
Nasal and tracheal mucosa explants were cultured 24 h in 
medium [15]. Afterwards, the apical surface of the epi-
thelial cells was exposed for 1 h at 37 °C to 8 mM ethyl-
ene glycol tetra-acetic acid (EGTA) (VWR International, 
Leuven, Belgium) as described by Galen et al. [16]. PBS 
was used as a control. Finally, explants were washed 3 
times to remove excess of EGTA before inoculation. To 
determine the viability of the cells in the explants after 
treatment with EGTA, an  in situ  Cell Death Detection 
Kit (Roche Diagnostics Corporation, Basel, Switzerland) 
was used based on terminal deoxynucleotidyl transferase 
dUTP nick end-labeling (TUNEL).
Respiratory epithelial cells
Nasal and tracheal epithelial cells were grown in tran-
swells. The medium from the wells was changed every 
day until confluency. After that, the cells were treated 
with 8  mM EGTA in PBS for 30  min prior to inocula-
tion; PBS was used as a control. The viability of the cells 
was assessed by ethidium monoazide bromide (EMA) 
staining. EGTA treatment did not cause a significant cell 
death.
Virus inoculation
Respiratory mucosal explants
After 24  h of cultivation of explants at the air-liq-
uid  interface, nasal and tracheal explants were treated 
with EGTA to dissociate ICJ or PBS as described above. 
Explants were submerged in 0.5  mL of BoHV-4 con-
taining medium  (107  TCID50/mL) and incubated for 1 h 
(37  °C, 5%  CO2). Before explants were placed back on 
the gauze, they were washed three times with PBS. The 
inoculated tissues were collected at 0  h, 24  h, 48  h and 
72 hours post-infection (hpi). All gathered explants were 
embedded in cryoprotection medium  [Methocel®, Fluka 
(Sigma)] and then frozen at −70 °C.
Respiratory epithelial cells
After respiratory epithelial cells became confluent in a 
transwell cell culture system, the cells were treated with 
EGTA or mock treated with PBS. Afterwards, the cells 
were inoculated with 100 µL of BoHV-4 (MOI = 2) at 
either the apical or the inverted basolateral surface for 
1 h (37 °C, 5%  CO2). The cells were washed 3 times with 
DMEM/F12. Fresh respiratory epithelial cell culture 
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medium was added to each well and cells were further 
incubated at the air–liquid interface. The cells were col-
lected at 0 h, 24 h, 48 h and 72 hpi and fixed in methanol 
for 20 min at −20 °C and stored dry at −20 °C until stain-
ing. The supernatant was used for titration.
Binding assay
The virus-binding studies were carried out to characterize 
the attachment of BoHV-4 to respiratory epithelial cells. 
After treated with EGTA or PBS, the cells were chilled on 
ice for 5  min and washed 3 times with cold PBS. Then, 
BREC were inoculated at an MOI of 10 with BoHV-4 at 
either the apical or inverted basolateral surfaces for 1 h 
at 4  °C. The cells were washed 3 times with cold PBS to 
remove unbound virus and then fixed in methanol for 
10  min.  A primary mouse monoclonal IgG2a antibody 
(Mab35) against the early-late glycoprotein complex gp6/
gp10/gp17 of BoHV-4 (1:1000 in PBS) was added. Next, 
cells were washed and incubated in a secondary goat 
anti-mouse IgG2a Alexa  fluor® 488 (Invitrogen) (1:200). 
Nuclei were counterstained with Hoechst 33342 (10 µg/
mL; Invitrogen) for 10 min at room temperature and the 
transwell was mounted with glycerol-DABCO. The total 
number of virus particles attached to the apical or baso-
lateral surfaces was counted. The percentage of BREC 
with bound BoHV-4 particles was calculated based on 
the number of cells with viral particles bound on the 
plasma membrane of 300 randomly selected cells.
Virus titration
BREC culture medium were collected at 0 h, 24 h, 48 h 
and 72  hpi for virus titration. MDBK cells were inocu-
lated for 1  h (37  °C, 5%  CO2) with serial 10-fold dilu-
tions  (100 to  10−7 in quadruplicate) of culture medium of 
BoHV-4 and mock inoculated BREC. Afterwards, MDBK 
cells were observed daily for cytopathic effect (CPE) for    
7–9 days. The virus titer was calculated using the method 
of Reed and Muench [17].
Immunofluorescent staining and confocal microscopy
Respiratory mucosal explants
At least 100 cryosections (20  μm) were made for each 
condition of both BoHV-4 and mock inoculated res-
piratory mucosae. Cryosections were fixed in methanol 
(−20  °C, 100%) for 20  min and washed in PBS. After-
wards, they were incubated with a primary mouse mono-
clonal IgG2a antibody (Mab35) against BoHV-4 for 1 h at 
37  °C, followed by an incubation with a secondary goat 
anti-mouse IgG2a Alexa  fluor® 488 (Invitrogen) (1:200).
Respiratory epithelial cells
In order to identify the BoHV-4 infected respiratory epi-
thelial cells, double immunofluorescence stainings were 
performed using different cell markers. Cells were incu-
bated with a primary mouse monoclonal IgG2a antibody 
(Mab35) against BoHV-4 for 1  h at 37  °C, followed by 
an incubation with a secondary goat anti-mouse IgG2a 
Alexa  fluor® 594 (Invitrogen) (1:200). Afterwards, a 
monoclonal mouse IgG1 anti-human cytokeratin (Dako, 
Glostrup, Denmark) (1:50 in PBS) was added, followed by 
a secondary goat anti-mouse IgG1  FITC® (Abcam, Cam-
bridge, UK) (1:200 in PBS) to stain epithelial cells. Finally, 
nuclei were counterstained with Hoechst 33342 (10 µg/
mL; Invitrogen) for 10 min at room temperature and cells 
were mounted with glycerol-DABCO. Analysis was per-
formed by a TCS SPE confocal system (Leica Microsys-
tems GmbH, Wetzlar, Germany).
Identification of single infected cells in the lamina propria
In order to identify the single BoHV-4 infected cells after 
inoculation, a double immunofluorescence staining was 
performed using different markers. Firstly, cryosections 
were incubated by a mixture of a primary mouse mono-
clonal IgG2a antibody (Mab35) against BoHV-4 mixed 
and a primary monoclonal mouse IgG1 antibody DH59B 
(VMRD Inc., Pullman) directed against CD172a cells of 
the monocyte lineage for 1  h at 37  °C, followed by an 
incubation with a mixture of a secondary goat anti-mouse 
IgG2a Alexa  fluor® 594 (Invitrogen) and a secondary goat 
anti-mouse IgG1 FITC (Abcam, Cambridge, UK). After-
wards, nuclei were counterstained with Hoechst 33342 
(10 µg/mL; Invitrogen) for 10 min at room temperature 
and slides were mounted with glycerol-DABCO. Analy-
sis was performed by a TCS SPE confocal system (Leica 
Microsystems GmbH, Wetzlar, Germany).
Statistical analysis
Data were statistically processed by Graphpad Prism 5.0 
(GraphPad Software, Inc., San Diego, CA, USA) for anal-
ysis of variance (ANOVA). The data are represented as 
means with standard deviation (SD) of three independent 
experiments. Results with p values of < 0.05 were consid-
ered significant.
Results
BoHV‑4 infects bovine nasal but not tracheal mucosa 
explants
BoHV-4 dissemination was examined in the established 
bovine respiratory mucosa explant system. Nasal and 
tracheal mucosae from three different animals were 
included and inoculated with BoHV-4. The explants were 
collected at different time points (0  h, 24  h, 48  h and 
72 hpi).
For the nasal explants, BoHV-4 positive cells were 
found at all collected time points post-inoculation. At 
24 hpi, single positive cells or cluster of a few cells were 
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observed in the epithelium and lamina propria. BoHV-4 
positive plaques were detected in the epithelium at 48 
and 72 hpi. The plaque did not cross the basement mem-
brane (Figure  1). No infection was observed in the tra-
cheal explants. These results show that BoHV-4 infects 
nasal but not tracheal mucosa explants.
BoHV‑4 cell tropism after inoculation in the lamina propria
To better understand the cell tropism of BoHV-4 after 
inoculation, double immunofluorescent stainings were 
performed on the nasal mucosa explants of the respira-
tory tract at 24 h and 48 hpi (Figure 2A). At 24 hpi, the 
percentage of infected cells in the epithelium that were 
identified as  cytokeratin+ was 90.2 ± 8.4%. A minority 
of infected cells was characterized as  CD172a+ in the 
epithelium. In the lamina propria, 83.3 ± 15.2% of the 
infected cells were  CD172a+ cells. Similar results were 
obtained at 48 hpi. The number of infected cells in the 
lamina propria at 48 hpi was not increased compared to 
the number at 24 hpi (Figures 2B and C). BoHV-4 might 
use  CD172a+ monocytic cells to cross the basement 
membrane to reach internal target organs.
EGTA can disrupt respiratory epithelial intercellular 
junctions
The intercellular spaces in the respiratory epithelium 
of both nasal and tracheal mucosa explants increased 
after treatment with 8 mM EGTA, but not after treat-
ment with PBS. Representative images of cryosections 
stained with modified Wright-Giemsa (Diff-Quick, 
Fisher Diagnostics, Newark, DE, USA) are shown 
in Figure  3. Cell viability in the respiratory mucosa 
explants did not significantly drop after treatment with 
8  mM EGTA compared with control PBS based on 
TUNEL-staining (Additional file  1). EGTA treatment 
disrupts intercellular junctions of respiratory epithelial 
cells without causing significant cell death.
Intercellular junctions protect respiratory mucosal 
explants to a certain extent from BoHV‑4 infection
The number of plaques, plaque latitude and num-
ber of single cells were determined after treatment 
with EGTA or control PBS. Representative pictures of 
nasal and tracheal mucosa explants are shown in Fig-
ures  4A and 5A, respectively. As shown in Figures  4B 
and 5B, the number of plaques per 100 cryosections 
of nasal mucosa explants increased from 5 ± 3 to 6 ± 3 
(p = 0.94) at 48 h and 9 ± 4 to 14 ± 6 (p = 0.15) at 72 hpi 
by treatment with EGTA. For tracheal mucosa explants, 
BoHV-4 infection was only found after treatment with 
EGTA. The number of plaques per 100 cryosections 
was 2 ± 2 at 48 h and 4 ± 2 at 72 hpi.
The plaque latitude is indicative for the lateral viral 
spread in the explant. For nasal mucosa explants, the 
average latitude increased from 64.3 ± 12.9  μm to 
81.7 ± 18.8  μm (p = 0.99) at 48  h and 173.0 ± 65.8  μm 
to 210.0 ± 68.7  μm (p = 0.84) at 72 hpi by treatment 
with EGTA. For tracheal mucosal explants, the aver-
age plaque latitude in the EGTA treated explants was 
52.0 ± 14.4 μm at 48 hpi and 76.7 ± 13.3 μm at 72 hpi. 
These results show that the integrity of ICJ protects 
respiratory mucosal explants to a certain extent from 
BoHV-4 infection.
Figure 1 Representative micrographs of BoHV‑4 (green) replication at 24, 48 h and 72 hpi in bovine respiratory nasal mucosa explants. 
The BM is visualized by mouse anti-collagen VII antibodies and goat anti-mouse Texas  Red® conjugate (red). Cell nuclei were counterstained with 
Hoechst (blue).
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BoHV‑4 preferentially infects basolateral surfaces 
of respiratory epithelial cells
To investigate whether BoHV-4 preferentially infects 
either apical or basolateral surfaces of BREC, the per-
centage of infection in both nasal and tracheal epi-
thelial cells upon apical or basolateral inoculation 
was evaluated at different time points (24, 48 and 72 
hpi) after treatment with EGTA or PBS (mock). Rep-
resentative pictures from BREC are shown in Fig-
ures 6A and 7A. For nasal epithelial cells, the average 
percentage of infection was 0.2 ± 0.1 at 24 h, 1.9 ± 1.6 
at 48  h and 4.4 ± 1.9 at 72  hpi after mock treatment 
with PBS and 1.1 ± 0.6 at 24  h, 4.7 ± 1.8 at 48  h and 
15.8 ± 3.8 at 72  hpi after treatment with EGTA when 
Figure 2 Double immunofluorescent stainings were performed at 24 h and 48 hpi in nasal mucosal explants. Representative confocal 
immunofluorescent images show BoHV-4 (red) infected  CD172a+ cells (green) in the lamina propria (A). Number of single BoHV-4 infected cells in 
both epithelium and lamina propria of nasal mucosa (B) and the percentage of  CD172a+ cells in the lamina propria (C) are given per 6 mm2 nasal 
mucosa at different time points after inoculation. All data are represented as means + SD of triplicate independent experiments.
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inoculated apically, whereas it was 1.1 ± 0.5, 8.1 ± 2.8 
and 24.5 ± 6.1 after treatment with PBS and 1.4 ± 0.2, 
8.2 ± 1.7 and 27.4 ± 6.8 after treatment with EGTA 
when inoculated basolaterally. For tracheal cells, the 
average percentage of infection was 0.01 ± 0.01 at 24 h, 
0.3 ± 0.2 at 48 h and 0.9 ± 0.4 at 72 hpi after treatment 
with PBS and 0.08 ± 0.02 at 24 h, 0.7 ± 0.3 at 48 h and 
4.9 ± 2.1 at 72 hpi after treatment with EGTA when 
inoculated apically, whereas it was 0.2 ± 0.1, 3.8 ± 0.8 
and 15.1 ± 5.9 after treatment with PBS and 0.3 ± 0.2, 
4.7 ± 1.8 and 20.8 ± 5.3 after treatment with EGTA 
when inoculated basolaterally (Figures  6B  and 7B). 
The culture medium of inoculated BREC was collected 
and titrated at different time points in order to get 
insights in virus production and shedding. The virus 
titer curves are given in Figures 6C and 7C. The virus 
titer increased over time after basolateral inoculation 
of both nasal and tracheal epithelial cells. For nasal 
epithelial cells, the virus titer was increased after treat-
ment with EGTA when inoculated apically, compared 
to treatment with PBS. These results demonstrate that 
basolateral inoculation of BoHV-4 results in a much 
higher infection in the respiratory epithelial cells than 
apical exposure. 
Increased epithelial cell susceptibility to BoHV‑4 
at the basolateral surfaces is correlated with the virus 
binding step
BoHV-4 binding to BREC after PBS or EGTA treatment 
was examined. Representative confocal images of BREC 
with bound BoHV-4 are shown in Figures 8A and B. The 
percentage of nasal epithelial cells with BoHV-4 parti-
cles after basolateral inoculation (35.3 ± 10.0) was sig-
nificantly higher than after apical inoculation (3.4 ± 0.7), 
whereas it was 25.6 ± 3.9 upon apical inoculation and 
37.0 ± 8.2 upon basolateral inoculation after treatment 
with EGTA. Moreover, the percentage of tracheal epi-
thelial cells with BoHV-4 particles after the basolateral 
inoculation (27.0 ± 11.5) was significantly higher than 
after the apical inoculation (0.7 ± 0.5), whereas it was 
10.3 ± 4.7 upon apical inoculation and 27.6 ± 13.4 upon 
basolateral inoculation after treatment with EGTA. The 
Figure 3 Disruption of ICJ in respiratory mucosal explants. Representative images of Diff-quick stained cryosections of the explants 1 h after 
treatment with PBS or EGTA.
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results are shown in Figure 8C and D. These results illus-
trate that BoHV-4 preferentially binds to basolateral sur-
faces of respiratory epithelial cells.
Discussion
Little is known about the primary replication and dis-
semination of gammaherpesviruses at the host respira-
tory mucosal entry port. Getting a better fundamental 
image on how the virus behaves at its primary replication 
site will provide insights for prevention and treatment 
Figure 4 BoHV‑4 infection of respiratory mucosal explants after PBS or EGTA treatment. Respiratory mucosal explants (nasal septum) were 
pre-incubated with PBS or EGTA, prior to inoculation with BoHV-4 for 1 h. Representative confocal images of BoHV-4 (green) replication at 0, 24, 48 
and 72 hpi (A). Cell nuclei were stained with Hoechst (blue). The number of plaques and plaque latitude were calculated in nasal mucosal explants 
(B). All data are represented as means + SD of triplicate independent experiments.
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on a rational basis. In the present study, bovine respira-
tory tract mucosal explants (nasal septum and trachea) 
and BREC were used for studying the BoHV-4 primary 
infection in its host. The explant model is the perfect 
compromise between in  vitro cell cultures and in  vivo 
animals. It was demonstrated that BoHV-4 replicates in 
the nasal mucosa explants, which is in  agreement with 
the in  vivo respiratory tract symptoms associated with 
BoHV-4 infections. Plaques were visible in the epithe-
lium at 48 hpi and they did not cross the basement mem-
brane, which is corresponding with our previous findings 
in genital tract mucosal explants [15]. In contrast, the 
Figure 5 BoHV‑4 infection of respiratory mucosal explants after PBS or EGTA treatment. Respiratory mucosal explants (trachea) were 
pre-incubated with PBS or EGTA, prior to inoculation with BoHV-4 for 1 h. Representative confocal images of BoHV-4 (green) replication at 0, 24, 
48 and 72 hpi (A). Cell nuclei were stained with Hoechst (blue). The number of plaques and plaque latitude were calculated in tracheal mucosal 
explants (B). All data are represented as means + SD of triplicate independent experiments.
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bovine alphaherpesvirus BoHV-1 causes an extensive 
epithelial plaque formation and exhibits a clear crossing 
of the basement membrane barrier [18]. The number and 
size of plaques in the nasal mucosa were slightly larger 
than in the vagina. This illustrates that BoHV-4 can easily 
use both the genital and respiratory tract for its first rep-
lication and subsequent horizontal transmission. The tra-
chea was not found to be infected at any collection time, 
which may be due to the absence of apical receptors at 
the epithelial cells, leading to a state of resistance.
The number of  single infected cells in the lamina 
propria was  rather low and most of them were identi-
fied as  CD172a+ cells. This indicates that BoHV-4 has 
a strong tropism for cells of the monocyte/macrophage 
lineage, which has been supported by previous stud-
ies [19–21]. Interestingly, Frederico et al. have recently 
used a homologous mouse model to study how the 
gammaherpesvirus, murine herpesvirus 4 (MuHV-4), 
enters the host via the upper respiratory tract [22]. They 
found and proposed that MuHV-4 first infects epithe-
lial cells, then exploits myeloid cells to reach and finally 
infect B lymphocytes [22, 23]. BoHV-4 uses alternative 
splicing to express high levels of gp180 in epithelial 
cells but reduced levels in myeloid cells to regulate its 
tropism [21]. A major BoHV-4 envelope protein, gp180, 
is massively glycosylated [24]. Machiels et al. found that 
if gp180 is present, it allows efficient infection of gly-
cosaminoglycans-positive [GAG(+)] cells like epithelial 
cells and if absent, it makes the virus more infectious 
for glycosaminoglycans-negative [GAG(-)] cells such as 
monocytes [25]. In our study, epithelial cells are likely 
the first target of BoHV-4. Next to that, monocyte/
macrophages are being infected and possibly hijack the 
Figure 6 Nasal epithelial cells were inoculated with BoHV‑4 (MOI = 2) at either the apical surface or basolateral surface after treatment 
with PBS or EGTA. Representative confocal images of BoHV-4 (red) infection in nasal epithelial cells (green) after treatment with PBS or EGTA at 
24 h, 48 h and 72 hpi; nuclei were stained with Hoechst (blue) (A). The scale bar represents 50 μm. The percentage of BoHV-4 infection was counted 
in 10 different fields of nasal epithelial cells after treatment with PBS or EGTA (B). In addition, the virus titers in culture medium were determined (C). 
Data are given as means + SD of triplicate independent experiments. These lower-case letters explain the p value. Significant differences (p < 0.05) 
are presented by the use of different letters.
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virus to cross the basement membrane, a mechanism 
previously described for alphaherpesvirus EHV-1 [26].
In order to examine the importance of tight junctions 
as a barrier for BoHV-4 infection, the respiratory mucosal 
explants were incubated with EGTA, a drug that disrupts 
the intercellular junctions. EGTA specifically induces a 
depletion of calcium ions from the culture medium of 
polarized epithelial cells which results in rapid splitting 
of the ICJ [27]. Recently, Van Cleemput et al. used EGTA 
to disrupt ICJ in equine respiratory mucosal explants and 
to study the impact on alphaherpesvirus EHV-1 infec-
tion [6]. The number of plaques (9 ± 4 to 14 ± 6, p = 0.15), 
plaque latitude (173.0 ± 65.8  μm to 210.0 ± 68.7  μm, 
p = 0.84) and number of single positive cells were 
enhanced for nasal mucosal explants by treatment with 
EGTA. BoHV-4 was also only able to infect the tracheal 
epithelium after disruption of the intercellular junctions. 
The infection in the trachea was significantly lower com-
pared to the infection in nasal mucosal explants. In con-
trast, alphaherpesvirus EHV-1 infection was significantly 
lower in nasal mucosal explants than in tracheal nasal 
explants [6].
Since BoHV-4 infection was enhanced after disrup-
tion of the respiratory epithelium integrity with EGTA, 
we hypothesized that its primary binding/entry recep-
tor is mainly located basolaterally. Therefore, BRECs 
were isolated and inoculated at either apical or baso-
lateral surfaces. We found that BoHV-4 preferentially 
binds to and infects both nasal and tracheal epithelial 
cells at basolateral surfaces based on the percentage of 
infected cells. This is in accordance with our virus shed-
ding when inoculated basolaterally. Virus production 
was increased after treatment with EGTA when inocu-
lated apically in nasal epithelial cells. Taking together 
Figure 7 Tracheal epithelial cells were inoculated with BoHV‑4 (MOI = 2) at either the apical surface or basolateral surface after 
treatment with PBS or EGTA. Representative confocal images of BoHV-4 (red) infection in tracheal epithelial cells (green) after treatment with PBS 
or EGTA at 24 h, 48 h and 72 hpi; nuclei were stained with Hoechst (blue) (A). The scale bar represents 50 μm. The percentage of BoHV-4 infection 
was counted in 10 different fields in tracheal epithelial cells after treatment with PBS or EGTA (B). In addition, the virus titers in culture medium 
were determined (C). Data are given as means + SD of triplicate independent experiments. These lower-case letters explain the p value. Significant 
differences (p < 0.05) are presented by the use of different letters.
Page 11 of 13Yang et al. Vet Res           (2019) 50:11 
all these findings, we may conclude that BoHV-4 
mainly uses a basolateral receptor. It agrees with 
the fact that single BoHV-4 infections are not caus-
ing severe respiratory problems, despite the power of 
BoHV-4 to replicate in the respiratory epithelial cells. 
We cannot exclude monocytic cells as primary infected 
cells that transfer virus to epithelial cells. These mono-
cytic cells can also play a crucial role in transferring the 
virus upon reactivation. The basolateral localization of 
the receptor will facilitate the infection of the epithelial 
cells upon release of the virus from reactivated mono-
cytic cells. One may defend the hypothesis that the 
epithelial cells are important both for entry and exit of 
the virus.
It is known that heparan sulfate (HS) serves as the ini-
tial receptor for several gammaherpesviruses. Interest-
ingly, heparan sulfate is present on the entire surface of 
the membrane of undifferentiated cells, but is seques-
tered at the basolateral cell surface of fully differenti-
ated cells [28, 29]. The process of adsorption of BoHV-4 
is mediated by the interaction of gB with heparin-like 
moieties on the cell surface [30]. Furthermore, infection 
with the murine gammaherpesvirus MuHV-4 depends 
on virion binding to heparan sulfate via gp70 or gH/gL 
Figure 8 BoHV‑4 binds to nasal and tracheal epithelial cells at apical and basolateral surfaces treated with PBS or EGTA. BREC were 
inoculated at 4 °C for 1 h with BoHV-4 particles (MOI = 10). Representative confocal images of nasal (A) and tracheal epithelial cells (B) with bound 
BoHV-4 particles (green), cell nuclei are stained in blue. The scale bar represents 20 μm. The percentage of cells with bound virus particles was 
calculated based on 10 random fields of 300 cells from nasal (C) and tracheal epithelial cells (D). Three independent experiments were performed 
and data are given as means + SD. Significant (p < 0.05) differences are indicated with an asterisk.
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[31–33]. The human gammaherpesvirus Kaposi’s sar-
coma associated herpesvirus (KSHV)-gB mediates viral 
binding and entry by interacting with cell surface heparan 
sulfate [34–36]. Previous studies examining the polarity 
of gammaherpesvirus infections have been conducted in 
continuous cell lines. To our knowledge, we were the first 
to use primary polarized respiratory epithelial cells to 
study gammaherpesvirus infections. Our results showed 
that the receptor is located at cellular basolateral sur-
faces and becomes apically accessible when intercellular 
junctions are impaired. The precise BREC binding/entry 
receptor for BoHV-4 will be identified in the near future.
In conclusion, the present study demonstrated that 
gammaherpesvirus BoHV-4 exhibits a specific strategy 
for respiratory tract invasion and subsequent spread. 
BoHV-4 infects epithelial cells in the nasal mucosa, 
rather than in the tracheal mucosa. BoHV-4 preferen-
tially binds to and infects respiratory cells at basolateral 
surfaces. The virus is not able to directly cross the base-
ment membrane; instead it hijacks  CD172a+ monocytic 
cells to reach internal target organs. Taken together, our 
results shed new light on the primary infection of gam-
maherpesvirus BoHV-4.
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